- Home
- SNTI vs BRFH Comparison
SNTI vs BRFH Comparison
Compare SNTI & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- BRFH
- Stock Information
- Founded
- SNTI 2016
- BRFH 2005
- Country
- SNTI United States
- BRFH United States
- Employees
- SNTI N/A
- BRFH N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- BRFH Packaged Foods
- Sector
- SNTI Health Care
- BRFH Consumer Staples
- Exchange
- SNTI Nasdaq
- BRFH Nasdaq
- Market Cap
- SNTI 39.6M
- BRFH 46.2M
- IPO Year
- SNTI N/A
- BRFH N/A
- Fundamental
- Price
- SNTI $1.37
- BRFH $2.91
- Analyst Decision
- SNTI Strong Buy
- BRFH
- Analyst Count
- SNTI 2
- BRFH 0
- Target Price
- SNTI $8.50
- BRFH N/A
- AVG Volume (30 Days)
- SNTI 120.0K
- BRFH 4.9K
- Earning Date
- SNTI 11-13-2025
- BRFH 10-23-2025
- Dividend Yield
- SNTI N/A
- BRFH N/A
- EPS Growth
- SNTI N/A
- BRFH N/A
- EPS
- SNTI N/A
- BRFH N/A
- Revenue
- SNTI N/A
- BRFH $10,979,000.00
- Revenue This Year
- SNTI N/A
- BRFH $23.09
- Revenue Next Year
- SNTI $150.00
- BRFH $41.03
- P/E Ratio
- SNTI N/A
- BRFH N/A
- Revenue Growth
- SNTI N/A
- BRFH 24.51
- 52 Week Low
- SNTI $1.26
- BRFH $1.81
- 52 Week High
- SNTI $16.94
- BRFH $4.60
- Technical
- Relative Strength Index (RSI)
- SNTI 37.01
- BRFH 47.96
- Support Level
- SNTI $1.33
- BRFH $2.78
- Resistance Level
- SNTI $1.39
- BRFH $3.10
- Average True Range (ATR)
- SNTI 0.08
- BRFH 0.13
- MACD
- SNTI 0.01
- BRFH -0.01
- Stochastic Oscillator
- SNTI 31.43
- BRFH 28.89
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About BRFH Barfresh Food Group Inc.
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.